Zoekresultaten - 95 results
Beheer van biologisch besmet afval afkomstig van activiteiten van ingeperkt gebruik van genetisch gemodificeerde en/of pathogene organismen: Richtlijnen en aanbevelingen.
Belgium, Brussels, p.29 (2021) Accession Number: D/2021/14.440/95 Keywords: biosafety management Waste Abstract: Het ingeperkt gebruik van genetisch gemodificeerde organismen (GGO ’s) en/of pathogenen ...
How to detect pathogens, leading to outbreaks, released accidentally or deliberately into the environment?
Publication Type: Scientific poster, presentation or proceeding Authors: Marie-Alice Fraiture; Nancy Roosens; Philippe Herman Source: 7th Annual International Symposium on Biosecurity and Biosafety ...
Engineering nucleases for gene targeting: safety and regulatory considerations.
Biosafety and biotechnology Manuscript versions: DOI: https://doi.org/10.1016/j.nbt.2013.07.001 File: Version: Published Full text access: Restricted Access Full text language: English Category: A1 FOS ...
Pulmonary artery haemorrhage in newborn calves following bluetongue virus serotype 8 experimental infections of pregnant heifers.
isolation facility (biosafety level 3) with a northern European outbreak strain of Bluetongue virus serotype 8 (BTV-8). The study was terminated 2 months after calving with necropsy of the dams and their ...
Biosafety of Gene Therapy Vectors Derived From Herpes Simplex Virus Type 14581
1875-5631 Keywords: a Absence adverse effects application AS assessment Belgium biosafety Case Cell clinic Clinical clinical trial Clinical trials Context Disorder Disorders dissemination Dna editorial effect ...
Biosafety of viral vectors commonly used in gene therapy and vaccination.
Publication Type: Peer reviewed scientific article Authors: Philippe Herman Source: Curr Gene Ther, Volume 13, Issue 6, p.383-4 (2013) Keywords: Genetic Therapy Genetic Vectors Hazardous Substances Humans Organisms, Genetically Modified Risk Assessment Va ...
Environmental risk assessment of clinical trials involving modified vaccinia virus Ankara (MVA)-based vectors.
renowned for its safety, several biosafety aspects need to be considered when performing the risk assessment of a recombinant MVA (rMVA). This paper presents the biosafety issues and the main lessons learned ...
General considerations on the biosafety of virus-derived vectors used in gene therapy and vaccination.
introductory paper gathers general considerations on the biosafety of virus-derived vectors that are used in human gene therapy and/or vaccination. The importance to assess the potential risks for human health ...
Laboratory-Acquired Infections in Belgium
Biosafety and biotechnology Full text language: English Category: C31 FOS Classification: 3.03 Health sciences ...
Bioveiligheid Klinisch labo
Keywords: biosafety bioveiligheid clinical medicine Service: Biosafety and biotechnology Biosécurité et biotechnologie Bioveiligheid en biotechnologie Category: C31 ...